| Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters. | Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters.
Záveský L, Jandáková E, Weinberger V, Minář L, Kohoutová M, Slanař O., Free PMC Article | 08/16/2024 |
| LncRNA MAGI2-AS3 promotes fracture healing through downregulation of miR-223-3p. | LncRNA MAGI2-AS3 promotes fracture healing through downregulation of miR-223-3p.
Dong Z, Hu B, Wang S, Wang M, Sun S, Liu X, Li D, Wu D., Free PMC Article | 07/10/2024 |
| Long Noncoding RNA MAGI2-AS3 Represses Cell Progression in Clear Cell Renal Cell Carcinoma by Modulating the miR-629-5p/PRDM16 Axis. | Long Noncoding RNA MAGI2-AS3 Represses Cell Progression in Clear Cell Renal Cell Carcinoma by Modulating the miR-629-5p/PRDM16 Axis.
Yan C, Wang P, Zhao C, Yin G, Meng X, Li L, Cai S, Meng B. | 08/22/2023 |
| Role of MAGI2-AS3 in malignant and non-malignant disorders. | Role of MAGI2-AS3 in malignant and non-malignant disorders.
Taheri M, Askari A, Hussen BM, Ghafouri-Fard S, Rashnoo F. | 05/28/2023 |
| Role of lncRNA MAGI2-AS3 in lipopolysaccharide-induced nucleus pulposus cells injury by regulating miR-374b-5p/interleukin-10 axis. | Role of lncRNA MAGI2-AS3 in lipopolysaccharide-induced nucleus pulposus cells injury by regulating miR-374b-5p/interleukin-10 axis.
Yu J, Li C., Free PMC Article | 05/8/2023 |
| lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the miR-106a-5p/RAB31 axis. | lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the miR-106a-5p/RAB31 axis.
Yang G, Li T, Liu J, Quan Z, Liu M, Guo Y, Wu Y, Ou L, Wu X, Zheng Y. | 03/27/2023 |
| MAGI2-AS3 and miR-374b-5p as Putative Regulators of Multiple Sclerosis via Modulating the PTEN/AKT/IRF-3/IFN-beta Axis: New Clinical Insights. | MAGI2-AS3 and miR-374b-5p as Putative Regulators of Multiple Sclerosis via Modulating the PTEN/AKT/IRF-3/IFN-β Axis: New Clinical Insights.
Kortam MA, Elfar N, Shaker OG, El-Boghdady NA, Abd-Elmawla MA. | 03/21/2023 |
| Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6. | Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6.
Wang J, Yang C, Cao H, Yang J, Meng W, Yu M, Yu L, Wang B., Free PMC Article | 03/7/2023 |
| LncRNA MAGI2-AS3 Inhibits Prostate Cancer Progression by Targeting the miR-142-3p. | LncRNA MAGI2-AS3 Inhibits Prostate Cancer Progression by Targeting the miR-142-3p.
Hu R, Wu P, Liu J. | 11/19/2022 |
| Long noncoding RNA MAGI2-AS3 regulates the H2O2 level and cell senescence via HSPA8. | Long noncoding RNA MAGI2-AS3 regulates the H(2)O(2) level and cell senescence via HSPA8.
Zhang Y, Qiao X, Liu L, Han W, Liu Q, Wang Y, Xie T, Tang Y, Wang T, Meng J, Ye A, He S, Chen R, Chen C., Free PMC Article | 07/16/2022 |
| LncRNA MAGI2-AS3 inhibits tumor progression and angiogenesis by regulating ACY1 via interacting with transcription factor HEY1 in clear cell renal cell carcinoma. | LncRNA MAGI2-AS3 inhibits tumor progression and angiogenesis by regulating ACY1 via interacting with transcription factor HEY1 in clear cell renal cell carcinoma.
Wang G, Li H, Hou Y. | 05/28/2022 |
| MicroRNA MiR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3. | MicroRNA MiR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3.
Xu Z, Chen Z, Peng M, Zhang Z, Luo W, Shi R, Wang L, Hong Y., Free PMC Article | 02/26/2022 |
| Roles of lncRNA MAGI2-AS3 in human cancers. | Roles of lncRNA MAGI2-AS3 in human cancers.
Kai-Xin L, Cheng C, Rui L, Zheng-Wei S, Wen-Wen T, Peng X. | 12/18/2021 |
| Long noncoding RNA MAGI2-AS3 inhibits bladder cancer progression through MAGI2/PTEN/epithelial-mesenchymal transition (EMT) axis. | Long noncoding RNA MAGI2-AS3 inhibits bladder cancer progression through MAGI2/PTEN/epithelial-mesenchymal transition (EMT) axis.
Shen D, Xu J, Cao X, Cao X, Tan H, Deng H. | 10/23/2021 |
| MAGI2-AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2. | MAGI2-AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2.
Xu X, Yuan X, Ni J, Guo J, Gao Y, Yin W, Li F, Wei L, Zhang J. | 09/11/2021 |
| LncRNA MAGI2-AS3 is downregulated in the distant recurrence of hepatocellular carcinoma after surgical resection and affects migration and invasion via ROCK2. | LncRNA MAGI2-AS3 is downregulated in the distant recurrence of hepatocellular carcinoma after surgical resection and affects migration and invasion via ROCK2.
Fang G, Wang J, Sun X, Xu R, Zhao X, Shao L, Sun C, Wang Y. | 08/28/2021 |
| MAGI2-AS3 rs7783388 polymorphism contributes to colorectal cancer risk through altering the binding affinity of the transcription factor GR to the MAGI2-AS3 promoter. | MAGI2-AS3 rs7783388 polymorphism contributes to colorectal cancer risk through altering the binding affinity of the transcription factor GR to the MAGI2-AS3 promoter.
Yang X, Wu S, Li X, Yin Y, Chen R., Free PMC Article | 08/7/2021 |
| MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis. | MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis.
Chang H, Zhang X, Li B, Meng X., Free PMC Article | 06/12/2021 |
| LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis. | LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis.
Tang C, Cai Y, Jiang H, Lv Z, Yang C, Xu H, Li Z, Li Y., Free PMC Article | 05/15/2021 |
| LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia. | LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia.
Chen L, Fan X, Zhu J, Chen X, Liu Y, Zhou H., Free PMC Article | 05/15/2021 |
| Long noncoding MAGI2-AS3 promotes colorectal cancer progression through regulating miR-3163/TMEM106B axis. | Long noncoding MAGI2-AS3 promotes colorectal cancer progression through regulating miR-3163/TMEM106B axis.
Ren H, Li Z, Tang Z, Li J, Lang X. | 03/13/2021 |
| LncRNA MAGI2-AS3 is down-regulated in intervertebral disc degeneration and participates in the regulation of FasL expression in nucleus pulposus cells. | LncRNA MAGI2-AS3 is down-regulated in intervertebral disc degeneration and participates in the regulation of FasL expression in nucleus pulposus cells.
Cui S, Liu Z, Tang B, Wang Z, Li B., Free PMC Article | 12/26/2020 |
| LncRNA MAGI2-AS3 Upregulates Cytokine Signaling 1 by Sponging miR-155 in Non-Small Cell Lung Cancer. | LncRNA MAGI2-AS3 Upregulates Cytokine Signaling 1 by Sponging miR-155 in Non-Small Cell Lung Cancer.
Li F, Hu Q, Pang Z, Xu X. | 10/24/2020 |
| LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis. | LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis.
Hao XZ, Yang K. | 10/10/2020 |
| Expression of long non-coding RNA MAGI2AS3 in human gliomas and its prognostic significance. | Expression of long non-coding RNA MAGI2‑AS3 in human gliomas and its prognostic significance.
Chen XD, Zhu MX, Wang SJ. | 09/12/2020 |